Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS44001222HTLV-1ENSG00000103222.20protein_codingABCC1NoNo4363P33527
TVIS44002936HTLV-1ENSG00000103222.20protein_codingABCC1NoNo4363P33527
TVIS44003735HTLV-1ENSG00000103222.20protein_codingABCC1NoNo4363P33527
TVIS44051162HTLV-1ENSG00000103222.20protein_codingABCC1NoNo4363P33527
TVIS44042164HTLV-1ENSG00000103222.20protein_codingABCC1NoNo4363P33527
TVIS44041953HTLV-1ENSG00000103222.20protein_codingABCC1NoNo4363P33527
TVIS44042163HTLV-1ENSG00000103222.20protein_codingABCC1NoNo4363P33527
TVIS44042162HTLV-1ENSG00000103222.20protein_codingABCC1NoNo4363P33527
TVIS44042161HTLV-1ENSG00000103222.20protein_codingABCC1NoNo4363P33527
TVIS44047431HTLV-1ENSG00000103222.20protein_codingABCC1NoNo4363P33527
TCGA Plot Options
Drug Information
GeneABCC1
DrugBank IDDB04851
Drug NameBiricodar
Target IDBE0000785
UniProt IDP33527
Regulation Type
PubMed IDs15014037
CitationsMinderman H, O'Loughlin KL, Pendyala L, Baer MR: VX-710 (biricodar) increases drug retention and enhances chemosensitivity in resistant cells overexpressing P-glycoprotein, multidrug resistance protein, and breast cancer resistance protein. Clin Cancer Res. 2004 Mar 1;10(5):1826-34.
GroupsInvestigational
Direct Classification
SMILESCOC1=CC(=CC(OC)=C1OC)C(=O)C(=O)N1CCCC[C@H]1C(=O)OC(CCCC1=CN=CC=C1)CCCC1=CN=CC=C1
Pathways
PharmGKBPA164924560
ChEMBLCHEMBL350775